Sana Biotechnology (SANA) Competitors $3.02 -0.36 (-10.53%) As of 03:04 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SANA vs. MENS, KYMR, SRRK, BHC, XENE, AMRX, HCM, RARE, NAMS, and MORShould you be buying Sana Biotechnology stock or one of its competitors? The main competitors of Sana Biotechnology include Jyong Biotech (MENS), Kymera Therapeutics (KYMR), Scholar Rock (SRRK), Bausch Health Cos (BHC), Xenon Pharmaceuticals (XENE), Amneal Pharmaceuticals (AMRX), HUTCHMED (HCM), Ultragenyx Pharmaceutical (RARE), NewAmsterdam Pharma (NAMS), and MorphoSys (MOR). These companies are all part of the "pharmaceutical products" industry. Sana Biotechnology vs. Its Competitors Jyong Biotech Kymera Therapeutics Scholar Rock Bausch Health Cos Xenon Pharmaceuticals Amneal Pharmaceuticals HUTCHMED Ultragenyx Pharmaceutical NewAmsterdam Pharma MorphoSys Jyong Biotech (NASDAQ:MENS) and Sana Biotechnology (NASDAQ:SANA) are both pharmaceutical products companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, media sentiment, profitability, valuation, analyst recommendations, institutional ownership, earnings and risk. Do insiders and institutionals hold more shares of MENS or SANA? 88.2% of Sana Biotechnology shares are held by institutional investors. 30.1% of Sana Biotechnology shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Does the media favor MENS or SANA? In the previous week, Jyong Biotech had 2 more articles in the media than Sana Biotechnology. MarketBeat recorded 6 mentions for Jyong Biotech and 4 mentions for Sana Biotechnology. Jyong Biotech's average media sentiment score of 0.64 beat Sana Biotechnology's score of 0.63 indicating that Jyong Biotech is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Jyong Biotech 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sana Biotechnology 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate MENS or SANA? Sana Biotechnology has a consensus target price of $8.00, suggesting a potential upside of 165.34%. Given Sana Biotechnology's stronger consensus rating and higher probable upside, analysts clearly believe Sana Biotechnology is more favorable than Jyong Biotech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jyong Biotech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Sana Biotechnology 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has higher valuation & earnings, MENS or SANA? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioJyong BiotechN/AN/AN/AN/AN/ASana BiotechnologyN/AN/A-$266.76M-$1.06-2.84 Is MENS or SANA more profitable? Jyong Biotech's return on equity of 0.00% beat Sana Biotechnology's return on equity.Company Net Margins Return on Equity Return on Assets Jyong BiotechN/A N/A N/A Sana Biotechnology N/A -91.96%-43.07% SummarySana Biotechnology beats Jyong Biotech on 5 of the 9 factors compared between the two stocks. Get Sana Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for SANA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SANA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SANA vs. The Competition Export to ExcelMetricSana BiotechnologyMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$717.00M$3.06B$5.75B$9.85BDividend YieldN/A2.26%3.95%4.02%P/E Ratio-2.8421.1531.3126.63Price / SalesN/A383.94459.79120.56Price / CashN/A44.4437.7659.36Price / Book5.808.0810.026.70Net Income-$266.76M-$54.08M$3.27B$265.68M7 Day Performance-16.25%2.44%3.26%3.46%1 Month Performance-38.22%3.56%4.45%1.11%1 Year Performance-48.46%18.78%44.34%24.00% Sana Biotechnology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SANASana Biotechnology3.2004 of 5 stars$3.02-10.5%$8.00+165.3%-41.7%$717.00MN/A-2.84380MENSJyong BiotechN/A$41.50-7.2%N/AN/A$3.16BN/A0.0031KYMRKymera Therapeutics3.0842 of 5 stars$43.62+2.3%$59.11+35.5%-13.6%$3.12B$47.07M-12.57170News CoverageSRRKScholar Rock4.5633 of 5 stars$31.52+0.4%$45.14+43.2%+280.5%$3.03B$33.19M-10.83140BHCBausch Health Cos4.694 of 5 stars$8.02-3.8%$9.00+12.2%+22.1%$2.97B$9.63B30.8520,700Analyst RevisionXENEXenon Pharmaceuticals2.2809 of 5 stars$37.82-1.1%$53.20+40.7%-5.0%$2.92B$9.43M-10.65210AMRXAmneal Pharmaceuticals3.268 of 5 stars$9.26-2.0%$11.60+25.3%+10.4%$2.91B$2.79B926.938,100Positive NewsInsider TradeHCMHUTCHMED2.6637 of 5 stars$16.43-0.1%$28.00+70.4%-13.6%$2.87B$630.20M0.001,811RAREUltragenyx Pharmaceutical4.6665 of 5 stars$29.70+0.0%$81.50+174.4%-47.8%$2.86B$560.23M-5.371,294NAMSNewAmsterdam Pharma3.6312 of 5 stars$25.40+1.3%$41.20+62.2%+45.9%$2.86B$45.56M-15.684Analyst ForecastInsider TradeMORMorphoSysN/A$18.96flatN/AN/A$2.86B$238.28M-5.45730Positive News Related Companies and Tools Related Companies MENS Competitors KYMR Competitors SRRK Competitors BHC Competitors XENE Competitors AMRX Competitors HCM Competitors RARE Competitors NAMS Competitors MOR Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SANA) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredThis strange black card is showing up across America"THIS is the Biggest Economic Story of 2025" While most Americans are focused on tariffs and inflation, the...Stansberry Research | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sana Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sana Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access